glp-1 manufacturing process Development of drug alone and carrier-based dry powder inhaler formulations GLP1 Therapies​

Heppner FL, Ransohoff RM, Becher B

Noticeable results like lighter skin tone and fade dark spots usually appear between 6 to 8 weeks

(PubMed) Clark LC, Combs GF, Jr., Turnbull BW, et al

If you see blood in the syringe, withdraw, discard the needle, and choose another site

The patients preference, comfort and ease with technology, willingness to engage with the device, caregiver support, interacting medications, and insurance coverage, along with device affordability, are important factors in determining which CGM is appropriate

The most common adverse reactions that led to discontinuation were somnolence and fatigue